Coherus BioSciences is an innovative oncology company focused on developing and commercializing immunotherapy treatments. Led by its approved PD-1 inhibitor LOQTORZI, the company boasts a robust pipeline of mid-stage clinical candidates targeting various cancers. Coherus aims to expand LOQTORZI's applications in non-small cell lung cancer (NPC) and explore synergistic combinations with its pipeline drugs and industry partners, driving advancements in immuno-oncology.
The Executive, Medical Communications is a key member of the Medical Affairs team, responsible for strategic input, leadership, management, and execution of scientific communication activities for immuno-oncology and biosimilar products. This role involves developing and executing publications, scientific communication plans, and contributing to scientific strategy and content delivery. The role requires deep knowledge of the disease area and alignment with company goals.
Coherus BioSciences is an innovative oncology company focused on developing and commercializing immunotherapy treatments. Led by its approved PD-1 inhibitor LOQTORZI, the company boasts a robust pipeline of mid-stage clinical candidates targeting various cancers. Coherus aims to expand LOQTORZI's applications in non-small cell lung cancer (NPC) and explore synergistic combinations with its pipeline drugs and industry partners, driving advancements in immuno-oncology.
Orca Bio